The Etoposide Capsules, cataloged under National Stock Number 6505-01-278-1124, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Mead Johnson & Company, Llc. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-278-1124 |
| Primary Part Number | 3091-45 |
| Item Name | Etoposide Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Mead Johnson & Company, Llc |
| Status | ACTIVE |
| Features Provided | INDIVIDUALLY SEALED |
| Primary Container Type | STRIP |
| Protective Storage Feature | ANTINEOPLASTIC DRUG AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| Capsule Primary Container Content Quantity | 20.000 |
| Active Medicament Medicinal Strength | 50.000 MILLIGRAMS ETOPOSIDE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| VEPESID 50 MG CAPSULAS | Bristol-Myers Squibb Farmaceutica Ltda (BRA) |
| 3091-45 PRIMARY | Mead Johnson & Company, Llc (USA) |
| NDC00015-3091-45 PRIMARY | Mead Johnson & Company, Llc (USA) |
| Reference | Meaning |
|---|---|
| VEPESID CAPSULES | 5/1 Secondary reference Mead Johnson & Company, Llc |
| VEPESID | 5/1 Secondary reference Mead Johnson & Company, Llc |
| 19-001-3117 | 6/9 Informative reference only Nato Stock Number Potential Interchangeability Link |
NSN 6505-01-278-1124 is a Etoposide Capsules, manufactured by Mead Johnson & Company, Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-278-1124 has 3 manufacturer part numbers on file: VEPESID 50 MG CAPSULAS (Bristol-Myers Squibb Farmaceutica Ltda), 3091-45 (Mead Johnson & Company, Llc), NDC00015-3091-45 (Mead Johnson & Company, Llc).
Key specifications for 3091-45: Features Provided: INDIVIDUALLY SEALED; Primary Container Type: STRIP; Protective Storage Feature: ANTINEOPLASTIC DRUG AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING; Capsule Primary Container Content Quantity: 20.000. 5 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.